通过多学科团队方法优化子宫内膜癌的结果
Lucia Mangone1, Francesco Marinelli1, Isabella Bisceglia1
1Epidemiology Unit, Azienda USL-IRCCS di Reggio Emilia, 42123 Reggio Emilia, Italy.
Healthcare (Basel, Switzerland)
|January 11, 2024
概括
多学科团队 (MDT) 方法对子宫内膜癌 (EC) 患者的结果产生了积极影响,特别是整体存活率,尽管复发率相似. 这突出了不断变化的患者人口统计和MDT.
科学领域:
- 在瘤学瘤学.
- 癌症研究 癌症研究
- 临床医学 临床医学
背景情况:
- 子宫内膜癌 (EC) 管理需要全面的策略.
- 多学科团队 (MDT) 方法对EC患者结果的影响是一个正在进行的调查领域.
- 了解患者的人口变化对于优化癌症护理至关重要.
研究的目的:
- 评估多学科团队 (MDT) 方法对子宫内膜癌 (EC) 患者结局的影响.
- 为了比较MDT和非MDT组之间的复发率,治疗和生存指标.
- 分析患者人口结构的变化及其对EC管理的影响.
主要方法:
- 从雷吉奥埃米利亚癌症登记处获得的2013-2020年数据的回顾性分析.
- 对319个使用MDT治疗的EC病例和324个未使用MDT治疗的病例的结果进行比较.
- 对复发率,无病生存率 (DFS) 和整体生存率 (OS) 的统计分析.
主要成果:
- 在MDT和非MDT组之间,复发率相似 (10%).
- 患有MDT的患者,特别是处于第一阶段的老年人,在一年内复发率更高 (79%对21%).
- 整体存活率 (OS) 在MDT组明显更好 (5年OS:87%与79%),尽管DFS没有显著差异.
结论:
- 多学科团队 (MDT) 方法对子宫内膜癌 (EC) 患者的整体存活率产生了积极影响.
- 随着患者人口结构的变化,包括老年和更晚期患者的增加,需要适应性护理策略.
- 持续评估MDT的有效性对于改善EC患者的治疗结果至关重要.
更多相关视频
09:48An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
8.1K
06:24Fertility Sparing Procedure using Carbon Dioxide Fiber Laser Vaporization of Ovarian Endometrioma
Published on: July 6, 2022
4.8K
相关概念视频
01:21Cancer Survival Analysis
353
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
353
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K